Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur

38,34 EUR
-0,32 % -0,12
14:32:06 Uhr, Baader Bank
Knock-Outs auf Novo Nordisk
Werbung
Mit Hebel
DZ Bank
Diese Werbung richtet sich nur an Personen mit Wohn-/Geschäftssitz in Deutschland. Der jeweilige Basisprospekt, etwaige Nachträge, die Endgültigen Bedingungen sowie das maßgebliche Basisinformationsblatt sind auf www.dzbank-wertpapiere.de veröffentlicht. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Kommentare 50.531
McLovin09
McLovin09, 9:52 Uhr
0

Also bei uns in DK ist sie bei -3%.......

Wenn man bedenkt wo die amis die aktie am freitag gehandelt haben, ist das positiv, das es nur-3% sind
AMK2020
AMK2020, 9:39 Uhr
0

“When we launch, we’ll go all in,” Novo’s Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. “It’s a major opportunity.” $NVO is preparing launch of wegovy pill outside US in several countries. Likely start early to mid Q3 NVO is also shaping the expectations. While they believe wegovy pill can be a big product outside US, they do caution people from expecting the same very steep sales curve. In US wegovy pill is significantly lower prices for start doses than wegovy pen. Even though NVO has not revealed pricing structure outside US yet, it’s clear that we should not expect to see the same repeated outside US. Price will likely be about the same as wegovy pen. And therefore it will not open the market further with lower prices as seen in US. Germany, UK, Norway, Denmark and Spain could likely be in the first wave of launch in Europe $LLY $VKTX

Das wird großartig
AMK2020
AMK2020, 9:39 Uhr
0

“When we launch, we’ll go all in,” Novo’s Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. “It’s a major opportunity.” $NVO is preparing launch of wegovy pill outside US in several countries. Likely start early to mid Q3 NVO is also shaping the expectations. While they believe wegovy pill can be a big product outside US, they do caution people from expecting the same very steep sales curve. In US wegovy pill is significantly lower prices for start doses than wegovy pen. Even though NVO has not revealed pricing structure outside US yet, it’s clear that we should not expect to see the same repeated outside US. Price will likely be about the same as wegovy pen. And therefore it will not open the market further with lower prices as seen in US. Germany, UK, Norway, Denmark and Spain could likely be in the first wave of launch in Europe $LLY $VKTX

Das wird großartig
McLovin09
McLovin09, 9:35 Uhr
1
In europa ist die Pille alleine auf dem Markt, würde mich wundern wenn sie die so günstig anbieten wie in den USA.
McLovin09
McLovin09, 9:34 Uhr
2
“When we launch, we’ll go all in,” Novo’s Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. “It’s a major opportunity.” $NVO is preparing launch of wegovy pill outside US in several countries. Likely start early to mid Q3 NVO is also shaping the expectations. While they believe wegovy pill can be a big product outside US, they do caution people from expecting the same very steep sales curve. In US wegovy pill is significantly lower prices for start doses than wegovy pen. Even though NVO has not revealed pricing structure outside US yet, it’s clear that we should not expect to see the same repeated outside US. Price will likely be about the same as wegovy pen. And therefore it will not open the market further with lower prices as seen in US. Germany, UK, Norway, Denmark and Spain could likely be in the first wave of launch in Europe $LLY $VKTX
f
franke69, 9:29 Uhr
0
Also bei uns in DK ist sie bei -3%.......
S
StalkaNr.1, 9:22 Uhr
0

30 ist um Anflug

Und wieder hast du falsch gelegen.
S
StalkaNr.1, 9:21 Uhr
0

Endlich macht Novo wieder das, was es am besten kann. Fallen ohne Ende

Schlecht gealtert. Leg dich wieder hin.
AMK2020
AMK2020, 9:19 Uhr
0
https://www.boerse-express.com/news/articles/novo-nordisk-aktie-207000-wegovy-rezepte-woechentlich-906285
AMK2020
AMK2020, 9:17 Uhr
0
Heute wird ein großartiger Tag ☝🏻
b
bm1986, 9:08 Uhr
0

Endlich macht Novo wieder das, was es am besten kann. Fallen ohne Ende

Hä? Steigt doch.
McLovin09
McLovin09, 9:00 Uhr
2

... das ist aber auch schon ne Woche alt

Das ist von heute. Eco war letzte woche
McLovin09
McLovin09, 8:59 Uhr
1
Gleich wieder 46$
Mannipenny
Mannipenny, 8:59 Uhr
0
... das ist aber auch schon ne Woche alt
McLovin09
McLovin09, 8:54 Uhr
3
$NVO $NOVO SB1 Markets reiterates its Buy rating on Novo Nordisk with a target price of DKK 350 after both Novo and Eli Lilly have presented news at the European Congress on Obesity (ECO 2026) in Istanbul. SB1 Markets says the data shows that a large proportion of the total weight loss is linked to early high responders, and this group appears to account for 20–30 percent of users. In Novo's STEP UP study, 84 percent of the weight loss was related to fat loss. In Lilly's study, SB1 Markets notes that patients using Wegovy maintained their weight better after switching to oral treatment compared to users of Zepbound. This is also interesting in light of the fact that Novo's oral drug shows almost 50 percent higher weight loss effect compared to Lilly's weight loss tablet (16.6 percent vs. 11.2 percent). Around 70-75 percent of users are expected to be normal responders. In this group, the difference between injectable and oral alternatives is significantly smaller compared to high responders: around 3.9 percent vs. 6.1 percent. These dynamics may lead to a trend in the future where normal responders switch to oral alternatives earlier, possibly after the first 4-6 months of injection treatment, SB1 Markets says. SB1 Markets also notes that a very high proportion of users at this stage of the launch of Novo Nordisk's Oral Wegovy (January to early May) are new to obesity treatment. This clearly indicates that Lilly's and Novo's oral drugs are likely to accelerate penetration in the US obesity market.
T
Tsindu12, 8:38 Uhr
1
Endlich macht Novo wieder das, was es am besten kann. Fallen ohne Ende
Mehr zu diesem Wert
Thema
1 Novo Nordisk nach Split
2 Novo Nordisk
Meistdiskutiert
Thema
1 DAX Hauptdiskussion +1,11 %
2 Dax Prognose +1,11 %
3 RHEINMETALL Hauptdiskussion +3,95 %
4 Linien und Wellen Austausch Forum -2,93 %
5 RENK (für normale, sachliche Kommunikation!) +2,37 %
6 AFC ENERGY Hauptdiskussion +1,50 %
7 Der Gold Club von Susiwong +0,24 %
8 NVIDIA Hauptdiskussion +1,19 %
9 SERVICENOW Hauptdiskussion +5,07 %
10 EUROPEAN LITHIUM Hauptdiskussion -0,20 %
Alle Diskussionen
Aktien
Thema
1 RHEINMETALL Hauptdiskussion +3,96 %
2 Linien und Wellen Austausch Forum -3,59 %
3 RENK (für normale, sachliche Kommunikation!) +1,34 %
4 AFC ENERGY Hauptdiskussion +1,50 %
5 NVIDIA Hauptdiskussion +1,18 %
6 SERVICENOW Hauptdiskussion +5,05 %
7 EUROPEAN LITHIUM Hauptdiskussion -0,20 %
8 Iris Energy +1,27 %
9 DeFi Technologies: Eine Perle? +0,33 %
10 Diginex -2,31 %
Alle Diskussionen